SAN DIEGO, Feb. 24, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 25 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating that the securities of the Company will remain suspended from quotation at the Company’s request until […]
Financial
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
BEDMINSTER, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that it has appointed a prominent cardiovascular medical and clinical development expert, James (“Terry”) J. Ferguson, M.D., FACC, FAHA, as its Chief Medical Officer. Dr. Ferguson is a well-recognized, industry leading […]
Nihon Kohden Appoints New CEO of North American Operations
IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the appointment of Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Dr. Wilson P. Constantine, who led the organization from April 2015 to February […]
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2018
PLANO, Texas, Feb. 21, 2019 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the fourth quarter and fiscal year ended December 28, 2018. Fourth Quarter 2018 Highlights GAAP Sales from continuing operations increased 0.3% and Non-GAAP Sales from continuing operations increased […]
Teleflex Reports Fourth Quarter and Full Year 2018 Results; Provides 2019 Guidance
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2018. Fourth quarter 2018 net revenues were $641.6 million, an increase of 7.8% compared to the prior year period. Excluding the impact of foreign currency exchange rate fluctuations, […]
Cardiovascular Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference
ST. PAUL, Minn.–(BUSINESS WIRE)–On Wednesday, February 27, 2019, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. Eastern Time. You may access the live audio webcast, as well […]
CHF Solutions, Inc. Announces 80% Revenue Growth for its Fourth Quarter and Provides Company Update
EDEN PRAIRIE, Minn., Feb. 20, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2018, which included the following highlights: Revenue for the fourth quarter ended December 31, 2018 increased 80.4 percent compared to the same period […]
REVA Announces Voluntary Suspension of Trading
SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 20 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating that the securities of the Company will be suspended from quotation immediately at the Company’s request […]
Micro Interventional Devices, Inc. Reaches Settlement Agreement with Neovasc, Inc.
NEWTOWN, Pa., Feb. 20, 2019 /PRNewswire/ — Micro Interventional Devices, Inc. (“MID”) announced today that it is has entered into a Settlement Agreement with Neovasc, Inc. MID (the “Plaintiffs”) filed a lawsuit in September 2018 in the U.S. District Court for the District of New Jersey including certain disputed allegations relating to Neovasc’s transcatheter mitral valve replacement (TMVR) technology […]
Neovasc Provides Corporate Update
VANCOUVER, Feb. 20, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies and in the development of minimally invasive devices for the treatment of refractory angina, today provided a corporate and operational update. Summary: Resolved previously-disclosed litigation […]



